| CRISPR Medicine | This is an overview of our interviews
Professor Stephanie Cherqui of University of California San Diego’s School of Medicine recently received a prestigious grant from the Californian...
Samantha Maragh from the US National Institute of Standards and Technology (NIST) discusses the significance of the recent publication of a set of...
Irish-Indian company CyGenica is on a mission to solve the huge challenge surrounding targeted intracellular delivery of gene-editing and other...
Researchers in California have developed a new method for high-yield genome engineering in primary cells using a hybrid ssDNA repair template and...
Researchers in the U.S. recently shed much needed light on the molecular mechanisms underpinning T cell exhaustion, revealing an epigenetic regulator...
Gene editing has revolutionised research and is set to change the treatment landscape for genetic diseases, with >100 ongoing clinical trials across...
Patients with collagen VI-related disorders experience progressive and debilitating disease. New research findings from Spain’s Institut de Recerca...
Verve Therapeutics recently announced the first human dosing with VERVE-101, an investigational base-editing therapy that is designed to treat...
